Statement of Use

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1553

Approved for use through 03/31/2024. OMB 0651-0054

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Statement of Use
(15 U.S.C. Section 1051(d))

To the Commissioner for Trademarks:
MARK: NUZYRA CENTRAL(Standard Characters, see http://uspto.report/TM/88133071/mark.png)
SERIAL NUMBER: 88133071


OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Paratek Pharmaceuticals, Inc., having an address of
      75 Park Plaza
      Boston, Massachusetts 02116
      United States
      Email: XXXX
Proposed: Paratek Pharmaceuticals, Inc., having an address of
      75 Park Plaza
      Boston, Massachusetts 02116
      United States
      Phone:
      Email: XXXX

The owner is submitting the following allegation of use information:

For International Class 005:
Current identification: Pharmaceutical preparations, namely, antibiotics

All ITU goods/services in this class are to be deleted


For International Class 016:
Current identification: Printed medication dosage and formulation charts; printed informational cards and brochures in the field of infectious disease; printed informational cards and brochures in the field of pharmaceutical preparations, namely, antibiotics

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/14/2019, and first used in commerce at least as early as 02/14/2019, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) pdf showing the mark affixed to printed materials with dosage charts and medical information.

Original PDF file:
SPN1-63764866-20210317152 112756641_._NUZYRA_CENTRA L_Class_16__Specimen.pdf
Converted PDF file(s) (6 pages)
Specimen File1
Specimen File2
Specimen File3
Specimen File4
Specimen File5
Specimen File6

Webpage URL: None Provided
Webpage Date of Access: None Provided

For International Class 036:
Current identification: Insurance consultancy services in the field of health; Insurance services, namely, insurance eligibility review and verification and consultation in the pharmaceutical industry; Pharmaceutical benefit management services; Insurance administration services, namely, assisting others with applying for insurance benefits

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/14/2019, and first used in commerce at least as early as 02/14/2019, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) pdf showing the mark affixed to a patient enrollment form used in connection with insurance benefits for pharmaceuticals.

Original PDF file:
SPN2-63764866-20210317152 112756641_._NUZYRA_CENTRA L_Class_36_and_44_Specime n.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2

Webpage URL: None Provided
Webpage Date of Access: None Provided

For International Class 039:
Current identification: Transportation of goods, namely, antibiotics; delivery and storage of goods; delivery of pharmaceuticals

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/14/2019, and first used in commerce at least as early as 02/14/2019, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) pdf showing the mark affixed to printed materials regarding the shipment and transportation of pharmaceuticals for patients.

Original PDF file:
SPN3-63764866-20210317152 112756641_._NUZYRA_CENTRA L_Class_39_Specimen.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2

Webpage URL: None Provided
Webpage Date of Access: None Provided

For International Class 044:
Current identification: Providing information in the fields of health, medicine, and pharmaceuticals for the treatment of infectious disease; Medical information services, namely, providing information to physicians, healthcare professionals, and patients on the topics of health issues, pharmaceutical products, and health awareness in the field of infectious diseases; Health care services, namely, providing patient access programs to provide eligible patients with streamlined access to drugs; Dispensing of pharmaceuticals; Providing an internet website for medical professionals and medical patients featuring medical information that enables users to enter, access, track, monitor and generate health and medical information

The mark is in use in commerce on or in connection with all of the goods/services, or to indicate membership in the collective organization listed in the application or Notice of Allowance or as subsequently modified for this specific class.

The mark was first used by the applicant, or the applicant's related company, licensee, or predecessor in interest at least as early as 02/14/2019, and first used in commerce at least as early as 02/14/2019, and is now in use in such commerce. The applicant is submitting one specimen for the class showing the mark as used in commerce on or in connection with any item in the class, consisting of a(n) pdf showing the mark affixed to a patient enrollment form used in connection with insurance benefits for pharmaceuticals.

Original PDF file:
SPN4-63764866-20210317152 112756641_._NUZYRA_CENTRA L_Class_36_and_44_Specime n.pdf
Converted PDF file(s) (2 pages)
Specimen File1
Specimen File2

Webpage URL: None Provided
Webpage Date of Access: None Provided

The applicant is not filing a Request to Divide with this Allegation of Use form. Correspondence Information (current):
      Keith Toms, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: ktoms@mccarter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bostontrademarks@mccarter.com; qkayton@mccarter.com
Correspondence Information (proposed):
      Keith Toms, Esq.
      PRIMARY EMAIL FOR CORRESPONDENCE: ktoms@mccarter.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bostontrademarks@mccarter.com; qkayton@mccarter.com

The docket/reference number is 124418-94501.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $400 will be submitted with the form, representing payment for the allegation of use for 4 classes.


Declaration

	The signatory believes that the applicant is the owner of the mark sought to be registered. For a trademark or service mark application, the mark is in use in commerce on or in connection with all the goods/services in the application or notice of allowance, or as subsequently modified. For a collective trademark, collective service mark, collective membership mark application, the applicant is exercising legitimate control over the use of the mark in commerce by members on or in connection with all the goods/services/collective membership organization in the application or notice of allowance, or as subsequently modified. For a certification mark application, the applicant is exercising legitimate control over the use of the mark in commerce by authorized users on or in connection with the all goods/services in the application or notice of allowance, or as subsequently modified, and the applicant is not engaged in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.
	The specimen(s) shows the mark as used on or in connection with the goods/services/collective membership organization in commerce.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, authorized users, members, and/or concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Signature: /Susan M. Perkins/      Date Signed: 03/18/2021
Signatory's Name: Susan M. Perkins
Signatory's Position: Vice President, Intellectual Property
Signatory's Phone: 000-000-0000
Signature method: Sent to third party for signature

PAYMENT: 88133071
PAYMENT DATE: 03/22/2021

Serial Number: 88133071
Internet Transmission Date: Mon Mar 22 12:15:56 ET 2021
TEAS Stamp: USPTO/SOU-XX.XX.XX.XX-202103221215566326
88-88133071-770ff443816d586e24ab5fae894c
93e9b291eaa73415eb6ce568914779d52c0fb18-
DA-15542963-20210317152112756641